US GAAP Financial Reports: All Assets, Liabilities and Equity (official 2013-2024 taxonomy)
Balance Sheet (Statement of Financial Position)
Taxonomy version: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | |||||||||
| Cash and cash equivalents | |||||||||
| Short-term investments | |||||||||
| Other undisclosed cash, cash equivalents, and short-term investments | |||||||||
| Net investment in lease, before allowance for credit loss | ✕ | ||||||||
| Net investment in lease, allowance for credit loss | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Restricted cash and investments | |||||||||
| Receivables | |||||||||
| Inventory, net of allowances, customer advances and progress billings | |||||||||
| Inventory | |||||||||
| Progress payments netted against inventory for long-term contracts or programs | |||||||||
| Other undisclosed inventory, net of allowances, customer advances and progress billings | |||||||||
| Prepaid expense | |||||||||
| Contract with customer, asset, after allowance for credit loss | |||||||||
| Capitalized contract cost | |||||||||
| Deferred costs | |||||||||
| Derivative instruments and hedges, assets | |||||||||
| Regulatory asset | |||||||||
| Funds held for clients | |||||||||
| Deferred rent asset | |||||||||
| Asset, held-in-trust | |||||||||
| Advances on inventory purchases | |||||||||
| Advance royalties | |||||||||
| Disposal group, including discontinued operation | |||||||||
| Asset, held-for-sale, not part of disposal group | |||||||||
| Deposits current assets | |||||||||
| Intangible current assets | |||||||||
| Business combination, contingent consideration, asset | |||||||||
| Other current assets | |||||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Assets held-for-sale | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Capital leases, lessor balance sheet, net investment in direct financing and sales type leases | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Income taxes receivable | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Asset recovery damaged property costs | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Costs in excess of billings | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Health care trust fund, assets limited as to use | ✕ | ✕ | ✕ | ✕ | |||||
| Deferred tax assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Financing receivable, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Accounts receivable, noncurrent, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Debt securities, held-to-maturity, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Net investment in lease, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Sales-type lease, net investment in lease, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Direct financing lease, net investment in lease, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Financial asset, amortized cost, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Debt securities, available-for-sale, accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ||||||
| Financing receivable, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Debt securities, held-to-maturity, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Net investment in lease, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Government assistance, asset | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed current assets | |||||||||
| Total current assets: | |||||||||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | ✕ | ||||||||
| Operating lease, right-of-use asset | ✕ | ||||||||
| Net investment in lease, before allowance for credit loss | ✕ | ||||||||
| Net investment in lease, allowance for credit loss | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Leveraged leases, net investment in leveraged leases disclosure, investment in leveraged leases | ✕ | ||||||||
| Inventory, real estate | |||||||||
| Nontrade receivables | |||||||||
| Property, plant and equipment | |||||||||
| Property, plant, and equipment, collections, not capitalized | ✕ | ✕ | |||||||
| Debt securities, available-for-sale, accrued interest, after allowance for credit loss | ✕ | ✕ | |||||||
| Oil and gas, successful efforts method, property and equipment, after accumulated depreciation, depletion, amortization, and impairment | |||||||||
| Oil and gas, full cost method, property and equipment, after accumulated depletion | |||||||||
| Long-term investments and receivables | |||||||||
| Due from related parties | ✕ | ✕ | |||||||
| Long-term investments | |||||||||
| Capital leases, lessor balance sheet, net investment in direct financing and sales type leases | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Unbilled change orders, amount expected to be collected after one year | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Accounts and financing receivable, after allowance for credit loss | |||||||||
| Other undisclosed long-term investments and receivables | |||||||||
| Intangible assets, net (including goodwill) | |||||||||
| Goodwill | |||||||||
| Intangible assets, net (excluding goodwill) | |||||||||
| Other undisclosed intangible assets, net (including goodwill) | |||||||||
| Prepaid expense | |||||||||
| Contract with customer, asset, after allowance for credit loss | |||||||||
| Capitalized contract cost, net | |||||||||
| Derivative instruments and hedges | |||||||||
| Regulated entity, other noncurrent assets | |||||||||
| Deposits noncurrent assets | |||||||||
| Deferred rent receivables, net | |||||||||
| Asset, held-in-trust | |||||||||
| Restricted cash and investments | |||||||||
| Disposal group, including discontinued operation, noncurrent assets | |||||||||
| Advance royalties | |||||||||
| Estimated insurance recoveries | |||||||||
| Customer funds | |||||||||
| Deferred costs | |||||||||
| Deferred income tax assets | ✕ | ||||||||
| Business combination, contingent consideration, asset | |||||||||
| Other noncurrent assets | |||||||||
| Investment, proportional amortization method, elected, amount | |||||||||
| Other receivable, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | ✕ | ||||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Assets held-for-sale, long lived | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Prepaid pension costs | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Costs in excess of billings | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Insurance receivable for malpractice | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Defined benefit plan, assets for plan benefits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Assets of disposal group, including discontinued operation | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Investments and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred tax assets, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Accounts receivable, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Financing receivable, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Debt securities, held-to-maturity, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Net investment in lease, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | |||||
| Government assistance, asset | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | |||||||||
| Other undisclosed assets | |||||||||
| TOTAL ASSETS: | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | |||||||||
| Settlement liabilities | ✕ | ✕ | ✕ | ||||||
| Interest and dividends payable | ✕ | ✕ | ✕ | ||||||
| Taxes payable | ✕ | ✕ | ✕ | ||||||
| Employee-related liabilities | ✕ | ✕ | ✕ | ||||||
| Accounts payable | |||||||||
| Accounts payable and other accrued liabilities | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Accrued liabilities | |||||||||
| Other undisclosed accounts payable and accrued liabilities | |||||||||
| Deferred revenue | ✕ | ||||||||
| Debt | |||||||||
| Deferred compensation liability | |||||||||
| Deferred rent credit | |||||||||
| Derivative instruments and hedges, liabilities | |||||||||
| Restructuring reserve | |||||||||
| Liability for uncertainty in income taxes | |||||||||
| Postemployment benefits liability | |||||||||
| Securities loaned | |||||||||
| Regulatory liability | |||||||||
| Provision for loss on contracts | |||||||||
| Estimated litigation liability | |||||||||
| Accrued environmental loss contingencies | |||||||||
| Asset retirement obligation | |||||||||
| Accrued capping, closure, post-closure and environmental costs | |||||||||
| Accrued reclamation costs | |||||||||
| Deferred gas purchases | |||||||||
| Disposal group, including discontinued operation | |||||||||
| Liabilities of business transferred under contractual arrangement | |||||||||
| Financial instruments subject to mandatory redemption, settlement terms, share value, amount | |||||||||
| Customer refund liability | |||||||||
| Self insurance reserve | |||||||||
| Program rights obligations | |||||||||
| Business combination, contingent consideration, liability | |||||||||
| Other liabilities | |||||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Billings in excess of cost | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred tax liabilities | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Due to related parties | ✕ | ✕ | |||||||
| Customer advances and deposits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Deferred lease income | ✕ | ✕ | ✕ | ✕ | |||||
| Government assistance, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed current liabilities | |||||||||
| Total current liabilities: | |||||||||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | |||||||||
| Long-term debt, excluding current maturities | |||||||||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Finance lease, liability | ✕ | ||||||||
| Other undisclosed long-term debt and lease obligation | |||||||||
| Liabilities, other than long-term debt | |||||||||
| Deferred lease income, after accumulated amortization | ✕ | ✕ | ✕ | ✕ | |||||
| Customer advances or deposits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Pension and other postretirement defined benefit plans, liabilities | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Accounts payable and accrued liabilities | |||||||||
| Accrued income taxes | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred revenue | ✕ | ||||||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Deferred compensation liability, classified | |||||||||
| Accumulated deferred investment tax credit | |||||||||
| Deferred gain on sale of property | |||||||||
| Billings in excess of cost | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred rent credit | |||||||||
| Asset retirement obligations | |||||||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Deferred income tax liabilities | ✕ | ||||||||
| Liability for uncertainty in income taxes | |||||||||
| Postemployment benefits liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liability, pension and other postretirement and postemployment benefits | |||||||||
| Coal supply agreement obligation | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Accrued environmental loss contingencies | |||||||||
| Customer refund liability | |||||||||
| Off-market lease, unfavorable | |||||||||
| Lease deposit liability | ✕ | ||||||||
| Financial instruments subject to mandatory redemption, settlement terms, share value, amount | |||||||||
| Estimated litigation liability | |||||||||
| Regulatory liability | |||||||||
| Due to related parties | ✕ | ✕ | |||||||
| Restructuring reserve | |||||||||
| Disposal group, including discontinued operation, liabilities | |||||||||
| Liabilities of business transferred under contractual arrangement | |||||||||
| Other liabilities | |||||||||
| Operating lease, liability | ✕ | ||||||||
| Self insurance reserve | |||||||||
| Program rights obligations | |||||||||
| Business combination, contingent consideration, liability | |||||||||
| Derivative instruments and hedges, liabilities | |||||||||
| Investment program, proportional amortization method, elected, commitment | |||||||||
| Government assistance, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed liabilities, other than long-term debt | |||||||||
| Other undisclosed noncurrent liabilities | |||||||||
| Total noncurrent liabilities: | |||||||||
| Other undisclosed liabilities | |||||||||
| Total liabilities: | |||||||||
| Commitments and contingencies | |||||||||
| Temporary equity, carrying amount | |||||||||
| Equity | |||||||||
| Equity, attributable to parent | |||||||||
| Preferred stock | |||||||||
| Preferred stock, shares subscribed but unissued, subscriptions receivable | |||||||||
| Common stock | |||||||||
| Treasury stock, value | |||||||||
| Common stock held by subsidiary | |||||||||
| Common stock, share subscribed but unissued, subscriptions receivable | |||||||||
| Common stock, value, subscriptions | |||||||||
| Additional paid in capital | |||||||||
| Deferred employee stock ownership plan, issuance of shares or sale of treasury shares | |||||||||
| Deferred compensation equity | |||||||||
| Accumulated other comprehensive income | |||||||||
| Retained earnings | |||||||||
| Unearned esop shares | |||||||||
| Other additional capital | |||||||||
| Receivable from officers and directors for issuance of capital stock | |||||||||
| Receivable from shareholders or affiliates for issuance of capital stock | |||||||||
| Warrants and rights outstanding | |||||||||
| Stockholders' equity note, subscriptions receivable | |||||||||
| Other undisclosed equity, attributable to parent | |||||||||
| Equity, attributable to noncontrolling interest | |||||||||
| Other undisclosed equity | |||||||||
| Total equity: | |||||||||
| Other undisclosed liabilities and equity | |||||||||
| TOTAL LIABILITIES AND EQUITY: | |||||||||
Income Statement (P&L)
Taxonomy version: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Other undisclosed income before gain (loss) on sale of properties | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Revenues | ||||||||
| Operating leases, income statement, lease revenue | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Amortization of lease incentives | ✕ | ✕ | ✕ | ✕ | ||||
| Underwriting income | ✕ | ✕ | ✕ | |||||
| Investment banking revenue | ✕ | ✕ | ✕ | |||||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Direct financing lease, revenue | ✕ | |||||||
| Direct financing lease, variable lease income | ✕ | |||||||
| Direct financing lease, interest income | ✕ | |||||||
| Sales-type lease, revenue | ✕ | |||||||
| Sales-type lease, variable lease income | ✕ | |||||||
| Sales-type lease, interest income | ✕ | |||||||
| Operating lease, lease income | ✕ | |||||||
| Revenue from related parties | ✕ | ✕ | ||||||
| Sublease income | ✕ | |||||||
| Brokerage commissions revenue | ✕ | ✕ | ✕ | |||||
| Sale of trust assets to pay expenses | ||||||||
| Insurance commissions and fees | ||||||||
| Contractually specified servicing fee, late fee, and ancillary fee earned in exchange for servicing financial asset | ||||||||
| Principal transactions revenue, net | ✕ | ✕ | ✕ | |||||
| Insurance agency management fee | ||||||||
| Gain on disposition of assets for financial service operations | ||||||||
| Premiums earned, net | ||||||||
| Net investment income | ||||||||
| Realized investment gains | ||||||||
| Revenues, excluding interest and dividends | ||||||||
| Other operating income | ||||||||
| Fee income | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Financial services revenue | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Market data revenue | ✕ | ✕ | ✕ | |||||
| Other income | ||||||||
| Other undisclosed revenues | ||||||||
| Cost of revenue | ||||||||
| Contract administration expense | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Cost of goods and services sold | ||||||||
| Financing interest expense | ||||||||
| Provision for loan, lease, and other losses | ||||||||
| Policyholder benefits and claims incurred, net | ||||||||
| Liability for future policy benefits, period expense (income) | ||||||||
| Policyholder account balance, interest expense | ||||||||
| Policyholder dividends, expense | ||||||||
| Deferred sales inducement cost, amortization expense | ||||||||
| Amortization of capitalized value of business acquired asset | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Present value of future insurance profits, amortization expense | ||||||||
| Amortization of mortgage servicing rights (msrs) | ||||||||
| Deferred policy acquisition costs, amortization expense | ||||||||
| Insurance tax | ✕ | ✕ | ||||||
| Financial services costs | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Amortization of value of business acquired (voba) | ||||||||
| Other cost of operating revenue | ||||||||
| Benefit claims in excess of related policyholder balances | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Merchant marine, operating-differential subsidy | ||||||||
| Other undisclosed cost of revenue | ||||||||
| Other undisclosed gross profit | ||||||||
| Gross profit: | ||||||||
| Operating expenses | ||||||||
| Government assistance, operating income, increase (decrease) | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other operating income, net | ||||||||
| Noninterest income, other operating income | ||||||||
| Other expenses | ||||||||
| Other nonrecurring (income) expense | ||||||||
| Phase-in plan, amount of capitalized costs recovered | ||||||||
| Other undisclosed other operating income, net | ||||||||
| Other undisclosed operating income | ||||||||
| Operating income: | ||||||||
| Nonoperating income | ||||||||
| Health care trust fund, administrative expense | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Health care trust fund, investment gains, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Investment income, nonoperating | ||||||||
| Gain on contract termination | ||||||||
| Gain on condemnation | ||||||||
| Loss from catastrophes | ||||||||
| Public utilities, allowance for funds used during construction, additions | ||||||||
| Gain, foreign currency transaction, before tax | ||||||||
| Sales-type lease, initial direct cost expense, commencement | ✕ | |||||||
| Gain on sale of capital leases, net | ✕ | ✕ | ✕ | ✕ | ||||
| Operating lease, initial direct cost expense, over term | ✕ | |||||||
| Gain on sale of leased assets, net, operating leases | ||||||||
| Gains on sales of other real estate | ||||||||
| Bank owned life insurance income | ||||||||
| Real estate investment partnership revenue | ||||||||
| Conversion gains and losses on foreign investments | ||||||||
| Profit from real estate operations | ||||||||
| Mortgage servicing rights (msr) impairment (recovery) | ||||||||
| Debt instrument, convertible, beneficial conversion feature | ||||||||
| Public utilities, allowance for funds used during construction, capitalized cost of equity | ||||||||
| Net periodic defined benefits expense (reversal of expense), excluding service cost component | ||||||||
| Government assistance, nonoperating income, increase (decrease) | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Health care trust fund, interest income | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Government assistance, nonoperating expense, decrease (increase) | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other nonoperating income | ||||||||
| Unusual or infrequent item, or both, net (gain) loss | ||||||||
| Other undisclosed nonoperating income | ||||||||
| Interest and debt expense | ||||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | ||||||||
| Income from continuing operations before equity method investments, income taxes: | ||||||||
| Income from equity method investments | ||||||||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Income from continuing operations before income taxes: | ||||||||
| Income tax benefit | ||||||||
| Other undisclosed income from continuing operations | ||||||||
| Income from continuing operations: | ||||||||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Gain on sale of properties, net of applicable income taxes | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Extraordinary item, gain | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |
| Income from discontinued operations | ||||||||
| Other undisclosed net income | ||||||||
| Net income: | ||||||||
| Net income attributable to noncontrolling interest | ||||||||
| Other undisclosed net income attributable to parent | ||||||||
| Net income attributable to parent: | ||||||||
| Preferred stock dividends and other adjustments | ||||||||
| Undistributed earnings (loss) allocated to participating securities, basic | ||||||||
| Other undisclosed net income available to common stockholders, basic | ||||||||
| Net income available to common stockholders, basic: | ||||||||
| Interest on convertible debt | ||||||||
| Convertible preferred dividends | ||||||||
| Dilutive securities, effect on basic earnings per share | ||||||||
| Other undisclosed net income available to common stockholders, diluted | ||||||||
| Net income available to common stockholders, diluted: | ||||||||
Comprehensive Income
Taxonomy version: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Net income: | ||||||||
| Net income attributable to redeemable noncontrolling interest | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other comprehensive income | ||||||||
| Other undisclosed comprehensive income | ||||||||
| Comprehensive income: | ||||||||
| Comprehensive income, net of tax, attributable to noncontrolling interest | ||||||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | ||||||||
| Comprehensive income, net of tax, attributable to parent: | ||||||||
US GAAP Financial Statements Source
These US GAAP reporting templates are based on the official 2013-2019 Financial Reporting Taxonomy. The cross mark (✕) indicates that the concept was not present in the taxonomy version for the corresponding year.
Top U.S. Companies' Financials
| Rank | Company | Revenue ($ millions) |
Assets | Market Cap |
|---|---|---|---|---|
| # 1 | Walmart Inc. | 648,125 | 252,399 | 744,664 |
| # 2 | Amazon.com Inc. | 574,785 | 527,854 | 2,215,618 |
| # 3 | Apple Inc. | 385,706 | 353,514 | 3,621,600 |
| # 4 | UnitedHealth Group Incorporated | 371,622 | 273,720 | 560,011 |
| # 5 | Berkshire Hathaway Inc. | 364,482 | 1,069,978 | 1,052,969 |
| # 6 | CVS Health Corporation | 357,776 | 249,728 | 74,347 |
| # 7 | Exxon Mobil Corporation | 344,582 | 376,317 | 517,962 |
| # 8 | McKesson Corporation | 311,443 | 66,512 | 78,867 |
| # 9 | Alphabet Inc. | 307,394 | 402,392 | 2,117,448 |
| # 10 | Cencora Inc. | 271,579 | 64,690 | 48,295 |
| # 11 | Costco Wholesale Corporation | 245,652 | 73,723 | 431,997 |
| # 12 | Microsoft Corporation | 227,583 | 470,558 | 3,204,285 |
| # 13 | Cardinal Health Inc. | 216,148 | 46,573 | 29,639 |
| # 14 | Chevron Corporation | 200,949 | 261,632 | 291,506 |
| # 15 | The Cigna Group | 195,265 | 152,761 | 93,754 |